UCLA Brain Tumor Imaging Laboratory (BTIL), is part of the Center for Computer Vision and Imaging Biomarkers, and a member of the UCLA Brain Tumor Program. Our research involves the development, testing, and implementation of advanced MRI and PET imaging biomarkers for the characterization of brain tumor biology and response evaluation in clinical trials.
- Image protocol standardization and quality control for multicenter clinical trials in brain tumors
- Imaging biomarkers for novel brain tumor therapies – Diffusion, perfusion, and functional imaging in brain tumors
- Radiogenomics and high-dimensional image processing
- Voxelwise spatiotemporal modeling of brain tumors using serial imaging
- Advanced MRI and PET techniques for brain tumor treatment evaluation, characterization, visualization, and quantification.
- Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi …
Harris RJ, Yao J, Chakhoyan A, Raymond C, Leu K, Liau LM, Nghiemphu PL, Lai A, Salamon N, Pope WB, Cloughesy TF, Ellingson BM.
Magn Reson Med. 2018 Apr 6.
Alterations in Cortical Thickness and Subcortical Volume are Associated With Neurological …
Woodworth DC, Holly LT, Mayer EA, Salamon N, Ellingson BM.
Neurosurgery. 2018 Mar 14
We are actively recruiting patients for multiple trials.
Learn More >
A joint meeting held on January 30, 2014, with the US Food and Drug Administration (FDA), National Cancer Institute (NCI), clinical scientists, imaging experts, pharmaceutical and biotech companies, clinical trials cooperative groups, and patient advocate groups developed a recommended standardized Brain Tumor Imaging Protocol (BTIP) for clinical trials.
Download Protocols >